To address patient demand, SFJ Pharmaceuticals closes the acquisition of Bentracimab
The company seeks to achieve U.S. regulatory approval for Bentracimab within the first-half of 2024.
top of page
Upload a PDF
Max File Size 15MB
Medical and Pharma Insider
Medical - Pharma - Biotech - Medical Devices - Healthcare - Telemedicine - Healthcare Technology - Healthcare IT
Your Source For Worldwide Business and Financial Opportunities
-
MedNews on financings, strategic relationships, products, services and technology, including launches
-
MedTalks videos featuring conversations with management of companies with business or financial objectives
.jpg)
Clinical
Trials
- Jan 4
- 3 min
Apnimed Closes $79.75 Million for Phase 3 Trials of an Oral Medication for Obstructive Sleep Apnea
Enrollment for the clinical trials is expected to begin in the second quarter of 2023
- Dec 27, 2022
- 2 min
Ablaze Pharmaceuticals and Yonghe Pharma to develop targeted radiopharma therapies
Under the agreement. Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze...
- Dec 22, 2022
- 4 min
University Hospitals Performs First Arthroscopic Surgeries in Ohio using ArthroFree Wireless Camera
Lazurite‘s ArthroFree is the first wireless surgical camera system to receive market clearance from the U.S. Food and Drug Administration...
- Nov 23, 2022
- 3 min
scPharmaceuticals Announces Pricing of $50 Million Public Offering
scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that have the potential...
- Nov 5, 2022
- 3 min
H.I.G. Capital acquires leading global clinical research organization Celerion
Headquartered in Lincoln, NE, Celerion is a leading global clinical research organization focused on providing end-to-end early stage clinic
- Oct 15, 2022
- 4 min
Integrated Drug Development Solution Company Altasciences Expands Support for Early Drug Development
The company is focused on innovative targeted radiopharmaceuticals for the diagnosis, monitoring, and therapy of cancer.
- Oct 8, 2022
- 4 min
RadioMedix raises $40 million to advance its alpha therapy platform for oncology
Targeted alpha therapies are currently considered one of the most advanced technologies available to treat patients with incurable cancers.
- Oct 2, 2022
- 4 min
CXL Ophthalmics announces $32 Million investment to advance its treatment for keratoconus
“EpiSmart has the potential to be a game-changer for the treatment for keratoconus.
- Sep 28, 2022
- 3 min
Aqualung Therapeutics Receives FDA Clearance of its IND for Acute Respiratory Distress Syndrome
Aqualung is an early-stage biotech company developing immune-focused therapeutic platform, eNamptor™.
- Sep 27, 2022
- 2 min
SeraNovo and Ildong Pharmaceutical to Collaborate on Multi-Compound Research Projects
Our team is addressing two core issues with our proprietary technology: enhancing bioavailability and reducing development time.
- Sep 1, 2022
- 3 min
OKYO plans fourth quarter IND filing for drug candidate to treat dry eye disease
OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO) is a life sciences and biotechnology company recently listed on Nasdaq .
- Aug 13, 2022
- 2 min
Clario invests in new technology to reduce translation times for clinical trials
For nearly 50 years, Clario has been delivering the leading endpoint technology solutions for clinical trials.
- Aug 5, 2022
- 2 min
Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy
Immunis’ FDA Phase 1/2a clinical trial is a study to assess IMM01-STEM in elderly participants with muscle atrophy.
- Aug 3, 2022
- 3 min
IDRx raises $122 million to transform cancer treatment with precision combination therapies
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies.
- Jul 29, 2022
- 3 min
HempMy Pet and Tarleton University announce positive results of their study using CBD on horses
HempMy Pet, a division of HM Health, LLC, offers CBD-infused products for dogs, cats, and horses.
- Jul 11, 2022
- 3 min
FIRST IN HUMAN SUBJECTS ENROLLED IN AQUALUNG THERAPEUTICS PHASE 1A STUDY OF ALT-100
Inflammation is a key feature in the pathogenesis of ARDS and the investigational product (IP) ALT-100 is an anti-inflammatory therapeutic..
- Jul 9, 2022
- 4 min
Kernal Biologics Raises $25 Million to Advance its mRNA 2.0 Technology for Oncology
There’s a major unmet need to improve outcomes for cancer patients and Kernal Bio has built a strong rational for the use of its novel mRNA
- Jun 5, 2022
- 3 min
Imaging Endpoints and ImaginAb partner to supply doses of the CD8 imaging agent for clinical trials
Imaging Endpoints is the world’s largest oncology-focused imaging CRO and has partnered with ImaginAb over the past decade.
- May 14, 2022
- 7 min
Mitsubishi Tanabe Pharma America obtains FDA approval of its RADICAVA ORS for the treatment of ALS
We continue to push the boundaries of innovation with RADICAVA ORS, an orally administered option allowing patients flexibility...
- May 7, 2022
- 2 min
Sen-Jam Pharmaceutical Enrolls Patients in its COVID Therapy Phase 2 Clinical Trial
Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories
- May 4, 2022
- 3 min
Four pharma solution providers launch Norstella to provide faster patient access to therapies
By launching Norstella, we’re taking the next step toward ensuring tha.t all patients have access to the therapies that they need
- Apr 15, 2022
- 4 min
With new funding, Pictor partners with Mobility Health for a SARS-CoV-2 antibody test
“The PictArray™ SARS-CoV-2 Antibody Test is a high performance, all-in-one, NP/SP COVID-19 antibody test with serological differentiation.
- Apr 7, 2022
- 2 min
ENDOVASCULAR ENGINEERING CLOSES ON $15 MILLION FOR VENOUS THROMBECTOMY SOLUTIONS
"With the close of this funding we will continue the journey from concept to clinical use/"
- Mar 26, 2022
- 3 min
Geneos Therapeutics closes on $17 million to advance its personalized cancer immunotherapy platform
Globally, liver cancers are the fourth most common cause of cancer-related death and ranked sixth in terms of annual incidence.
- Mar 24, 2022
- 3 min
Sen-Jam Pharmaceutical partners with KVK Tech for Covid oral therapeutic
Sen-Jam and KVK Tech will complete their phase II clinical trials or their oral COVID-19 drug, to have a finished product in 9-12 months.
- Mar 21, 2022
- 3 min
Triumvia Immunologics completes $100 million round for its T cell therapeutics
“Cell therapies have become an essential modality in the oncology therapeutic arsenal and a priority for many biopharma companies.
- Mar 2, 2022
- 2 min
Alcami, the contract development and manufacturer adds formulation development laboratory
Alcami serves pharmaceutical and biotech companies of all sizes providing customizable and innovative solutions
- Feb 28, 2022
- 4 min
Algernon Pharmaceuticals starts chronic kidney disease research program
Algernon is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds.
- Feb 19, 2022
- 2 min
Dizal Pharmaceutical obtains FDA Fast Track Designation for its drug for Refractory T-Cell Lymphoma
Dizal has a portfolio of innovative therapies for the treatment of cancer, immunological diseases and chronic kidney diseases.
- Feb 14, 2022
- 5 min
Otsuka and Sunovlon start Phase 3 trials for a treatment for biopolar depression
Bipolar disorder affects approximately 12.6 million individuals in the United States and an estimated 29 million people worldwide.
- Feb 12, 2022
- 4 min
Orthox raises $12.5 million to begin clinical trials for knee cartilage repair
Orthox's technology, originating from Oxford University, is a revolutionary tissue scaffold based on fibroin, a tissue regenerative protein.
- Feb 7, 2022
- 3 min
Third Pole Therapeutics closes on $25 million for trials of its wearable medical device for COPD
Third Pole has created a scalable technology that delivers nitric oxide for inhalation, instantly,on-demand, and in unlimited quantities.
- Feb 6, 2022
- 2 min
Paraxel and Dassault's Medidata extend partnership to improve decentralized clinical trials
More than one million users across 1,900+ customers and partners access the world's most trusted platform for clinical development and data
- Feb 2, 2022
- 5 min
4D pharma announces positive data from Part A of its Phase I/II trial for the treatment of asthma
The global asthma therapeutics market is projected to reach $23.1 billion by 2023.
- Jan 31, 2022
- 3 min
PrecisionLife closes on financing to advance its AI-led drug discovery for precision medicine
PrecisionLife is changing the way the world looks at predicting, preventing, and treating chronic disease.
- Jan 25, 2022
- 2 min
KalVista Pharmaceuticals (NASDAQ: KALV) publishes data on its trials for hereditary angioedema
KalVista Pharmaceuticals isfocused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases.
- Jan 24, 2022
- 4 min
BenchSci closes on $63 million to expand machine learning technology for pharmacelutical companies
"We strongly believe that the preclinical R&D market remains largely untapped and that BenchSci can become a category-defining leader...
- Jan 22, 2022
- 2 min
Parity Technologies partners with MediLedger Network to bring blockchain solutions to life sciences
The MediLedger Network is the leading blockchain-powered network for automatically settling trading partner transactions in Life Sciences.
- Jan 21, 2022
- 4 min
Yingli Pharma and MD Anderson partner for preclinical and clinical oncology programs
Yingli’s experience in medicinal chemistry with MD Anderson’s clinical and translational resources will advance therapeutic candiates.
- Jan 15, 2022
- 2 min
RealTime, the clinical research technology leader raises growth funding
RealTime provides software for clinical trial research sites, site networks, sponsors and CROs to manage complex clinical research processes
- Jan 6, 2022
- 3 min
Avenge Bio raises $48 million to advance research for treatment of ovarian cancer
Avenge Bio is developing transformative cell-based immunotherapeutic products for the treatment of intractable solid tumors.
- Dec 24, 2021
- 3 min
Oncorena lands financing for its clinical study for patients with advanced kidney cancer
Oncorena's Phase I/II clinical trial of orellanine will enrol patients with advanced renal cancer already on dialysis due to renal failure.
- Dec 23, 2021
- 2 min
Cardiovascular startup Filterlex Medical receives €7M from the European Innovation Council
The use of funds will include clinical program expansion and commercialization of the CAPTIS full-body embolic protection system.
- Dec 10, 2021
- 4 min
Iterion Therapeutics starts phase 1 clinical trial for non-small cell lung cancer
Iterion Therapeutics is a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics.
- Nov 25, 2021
- 3 min
Lixte Biotechnology (Nasdaq: LIXT) resumes enrollment for its trial for recurrent, malignant tumors
THE study is designed to determine the extent to which LB-100 enters recurrent GBMs and related brain tumors.
- Nov 21, 2021
- 3 min
Healint and Nestle Health Science Partners initate a virtual study on ketogenic migraine treatment
Migraine is the sixth most disabling illness in the world, which affects around a billion people worldwide.
- Nov 19, 2021
- 3 min
Alpheus Medical raises $16 million for human trials of therapy for solid body cancers
The company's lead product utilizes a novel, non-invasive drug-device combination for outpatient treatment of rGBM.
- Nov 6, 2021
- 3 min
Preclinical Parthenon Therapeutics closes on $65 million to advance anti-cancer therapeutics
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME).
- Oct 14, 2021
- 3 min
Contract Research Organization Sai Life Sciences expands capabilities and funding
Sai Life Sciences is a CRO-CDMO that enables pharma and biotech companies to accelerate the discovery and development of small molecules.
bottom of page